CME Group Inc. · NASDAQ:CME
CME — Cbot Holdings — Merger or Acquisition (March 2007)
38 slides from CME's merger presentation, Mar 22, 2007
Slide 1: CME/CBOT Proposed Merger Investor Presentation
CME/CBOT Proposed Merger March 22, 2007 Investor Presentation
Slide 2: Discussion of Forward-Looking Statements
Discussion of Forward-Looking Statements Forward-Looking Statements This presentation may contain forward-looking information regarding Chicago Mercantile Exchange Holdings Inc. and CBOT Holdings, Inc. and the combined company after the completion of the merger that are intended to be covered by the
Slide 3: Terry Duffy, Executive Chairman
Terry Duffy Executive Chairman
Slide 4: Strategically Attractive, Financially Compelling Combination
Strategically Attractive Financially Compelling Combination will establish the world’s largest derivatives exchange to the benefit of shareholders, members and customers CME ’ s superior offer has larger and more immediate benefits to CBOT shareholders and members • Solidifies combined company’s sta
Slide 5: Craig Donohue, Chief Executive Officer
Craig Donohue Chief Executive Officer
Slide 6: Operationally, Strategically, Financially: Better Together
Operationally Strategically Financially Better together ICE’s proposal • offers CBOT shareholders a weaker currency • will limit CBOT’s comparative future growth potential and value creation opportunities • exaggerates the estimated synergies • poses significant execution and integration risks that
Slide 7: OTC derivatives markets are larger and growing faster
OTC derivatives markets are larger and growing faster $0 $50,000 $100,000 $150,000 $200,000 $250,000 $300,000 DEC 2001 DEC 2003 DEC 2005 ($ in billions) $23,764 $111,178 $36,787 $197,167 $57,816 $297,670 Exchange-traded OTC CAGR 2001-2005 OTC – 28% Exchange Traded – 25% Total Value Outstanding Posit
Slide 8: ICE's vague structure to preserve CBOE exercise rights is not differentiating
ICE’s vague structure to preserve CBOE exercise rights is not a differentiating factor CBOE exercise rights • ICE has proposed same exact structure • ICE has not identified specific changes • ICE offered CBOT shareholders no guarantees or promises • CBOE has not consented to ICE’s proposal
Slide 9: WTI Average Daily Volume: NYMEX on CME Globex vs. ICE
WTI Average Daily Volume NYMEX on CME Globex vs. ICE CME successfully integrates NYMEX, and takes market share back from ICE (by month; notionally adjusted; contracts in thousands) JUN JUL AUG SEP OCT NOV DEC JAN NYMEX WTI on CME Globex ICE WTI The Electronic Trading Comparison FEB MAR To date Sourc
Slide 10: CME offers extremely liquid FX markets
CME offers extremely liquid FX markets – FX is CME’s third largest product and is currently averaging the same amount of volume as all ICE futures and all NYBOT combined Monthly Average Daily Volume Total ICE Futures & NYBOT (contracts in thousands) CME FX Volume equals ICE/NYBOT total volume, and s
Slide 11: ICE volume and revenue are limited to energy and soft commodity markets
ICE volume and revenue are limited to the energy and soft commodity markets Diversity of ADV and Revenue CME Q406 ADV Interest Rates 56% Equity Mini 30% Equity Standard 3% FX 10% Commodities & Alt Investments 1% ICE/NYBOT Q406 ADV Energy 87% Soft Commodities 13% CME Q406 Clearing & Transaction Reven
Slide 12: ICE's unseasoned stock declined 20%
In a challenging market, ICE’s unseasoned stock declined 20% Indexed Price Performance Quality of Currency Characteristics • ICE’s volatility is 30% higher than CME’s • Since ICE’s IPO, ICE’s P/E has fluctuated more than 26 points vs. CME’s fluctuation of 10 points over the same time period • ICE ha
Slide 13: CME is the largest global derivatives exchange
CME is the largest global derivatives exchange and has a strong partnership with the leading energy exchange, while ICE/NYBOT is not the largest in any segment Sources: Company press releases and SEC filings We operate in a global marketplace 1,000 2,000 3,000 4,000 5,000 6,000 5,313 3,269 4,628 2,0
Slide 14: OTC opportunities in CBOT more effectively pursued with CME's resources
OTC opportunities in CBOT will be more effectively pursued by leveraging CME’s resources, experience and investments across both large and small OTC market segments $0 $45,000 $90,000 $135,000 $180,000 $225,000 $270,000 Interest Rates FX Credit Default Equity-linked Commodity OTC opportunities are l
Slide 15: Jamie Parisi, Chief Financial Officer
Jamie Parisi Managing Director & Chief Financial Officer
Slide 16: Expected cost savings of $125+ million annually
Expected cost savings of $125+ million annually, beginning in year two post-close CME/CBOT planned synergies Technology Related 50% Trading Floor / Operations 15% Administrative 35% Cost Savings Areas Total: $125+ million
Slide 17: ICE's synergy estimates are not based in reality
ICE’s synergy estimates are not based in reality ICE ’ s exaggerated synergies • The $50M revenue synergies are highly speculative ICE provided no quantifiable basis for revenue synergies CME’s revenue synergies with CBOT would be greater driven by CME Globex distribution and speed, as well as adjac
Slide 18: ICE/CBOT cost synergies represent 43% of combined expense base
ICE/CBOT cost synergies represent 43% of the combined expense base versus the 9% average for comparable deals ICE ’ s cost synergies are inflated relative to other mergers 43% 19% 10% 6% 6% 4% 9% 7% 13% 11% 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 50% ICE / CBOT CME / CBOT Nasdaq / INET ECN NYSE / Euro
Slide 19: Kim Taylor, President CME Clearing
Kim Taylor Managing Director & President CME Clearing
Slide 20: Benefits of CME Clearing
Benefits of CME Clearing • Offers rock solid operational reliability • Provides high degree of risk management and financial integrity • Delivers low-cost services • Leverages scalability and adaptability
Slide 21: NYBOT would need to scale up clearing capacity 18 times
NYBOT would need to scale up clearing capacity on day 1 more than 18 times to accommodate CBOT average volume Average Transactions Average Volume Operational capacity and reliability • CME has operational capacity to clear business of CBOT’s magnitude Notes: CME and CBOT YTD through 3/16/07, NYBOT Y
Slide 22: NYBOT would need to scale up clearing capacity to handle CBOT peak volume
NYBOT would need to scale up clearing capacity by 30 times to handle CBOT peak volume Peak Transactions Peak Volume Operational capacity and reliability • Clearing operational capacity & reliability at peak activity levels is extremely critical to CBOT business Note: CME and CBOT Peak volumes occurr
Slide 23: ICE's net margining proposal is a step backwards
ICE’s net margining proposal is a step backwards from CME’s optimal margining innovation Risk management and financial integrity • CME offers important innovation over clearing houses that offer solely net or gross margining: CBOT house portfolios are margined net by CME CBOT customer portfolios hav
Slide 24: CME has real-time risk management 24 hours a day
CME has real-time risk management 24 hours a day, 6 days a week, ensuring early detection of large risk exposures Risk management and financial integrity • CME Clearing is widely recognized as the industry leader in risk management • 109 year, default-free history • Industry leading risk management:
Slide 25: CME experienced managing mark-to-market flows greater than NYBOT
CME is experienced with managing mark-to-market flows 40 times greater than NYBOT Risk management and financial integrity • CME Clearing has extensive experience & capabilities to risk manage business of CBOT’s scope & scale CME CBOT NYBOT Open Interest : 44.5M 15.9M 2.5M Average daily MTM: $1.8B $.
Slide 26: ICE cross-margining savings don't compare to CME/CBOT margin savings
ICE cross-margining savings of $50 million doesn’t compare to margin savings with CME/CBOT Cost and capital efficiencies • The combination of CME & CBOT products under a single clearing house resulted in significant capital savings & efficiency for the market Potential Margin Efficiencies Lost: $700
Slide 27: Growth capabilities of CME Clearing
5 of the top 10 CBOT volume leaders are not NYBOT clearing members Growth capabilities • With its current capabilities, CME Clearing has created a strong foundation to continue growing the combined business of the CME & CBOT • Clearing provides the following capabilities to support or drive growth i
Slide 28: Phupinder Gill, President & Chief Operating Officer
Phupinder Gill President & Chief Operating Officer
Slide 29: 2/3 of mergers fail to increase shareholder value due to poor integration
2/3’s of mergers fail to increase shareholder value due to poor integration execution CME ready to integrate, while ICE offer has significant execution risk Slow Integration 66% Low revenues, cash, profitability PWC Poor Strategy 50% Poor cash flow relative to peers Healy et. al. Weak Core Business
Slide 30: CME has spent $360M over 5 years on capital reinvestment, ICE less than $70M
To support scaling of technology infrastructure, CME has spent $360M over the past 5 years in capital reinvestment, while ICE has spent less than $70M '02 '03 '04 '05 '06 '07 Source: CME 2006 and 2003 10-Ks, CME press release dated 1/30/07, ICE 8-K filed 3/13/07, ICE 2006 10-K, ICE S-1 filed 3/22/05
Slide 31: Slide 31
Slide 32: CME Globex capacity: orders grew 30x while round trip time fell 80%
While orders/transactions grew by a factor of 30, the average round trip time fell 80% from its 2004 level CME Globex has the capacity to handle large transaction volumes at a high speed Globex Transaction Volume (2003 to 2007) 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 Open Inte
Slide 33: CME offers robust functionality for fast, protected and efficient trading
CME Offers Critical Customer Protection Functionality CME Offers Robust and Efficient Matching ICE CME CME Offers Theoretical Price Function for Spread Leg Price Assignment CME: Robust functionality for fast, protected and efficient trading Pro rata with configuarable TOP minimum/maximum quantity or
Slide 34: Customers win with CME
“We are putting tremendous demands on traditional NYBOT clearers and customers” (to bring the products up electronically) – Jeff Sprecher, CEO, 2/7/07 Customers win with CME … A CME transaction… • Retains Common Clearing Link Efficiencies CME/CBOT retains $700M - $1B+ cross margining efficiencies ve
Slide 35: Chicago Mercantile Exchange
cmeé Chicago Mercantile Exchange
Slide 36: CME played a central role in successful conclusion of major market events
CME played a central role in the successful conclusion of a number of events CME Clearing has proven to be a global leader in risk management • Black Monday – Dow fell 22% on October 19, 1987 • Drexel Burnham Lambert Parent– December 21, 1988 pleaded guilty to insider trading. February 13, 1990 DBL
Slide 37: CME Clearing's risk management has prevented any clearing firm defaults
Unlike NYBOT, CME Clearing’s approach to risk management has prevented any CME clearing firm defaults NYBOT and the Klein default • First West owned by NYFE (a division of NYBOT) Chairman Norman Eisler defaults causing Klein to default to NYBOT on May 17, 2000 The firm is undercapitalized (pro forma
Slide 38: CME supports Give-up functionality and a 2-way API
CME has supported Give-up functionality for 15 years & a 2-way API for the past 5 years. Both are critical to processing CBOT business NYCC CME Clearing Technology Operational functionality • CBOT business depends heavily on post-trade processing functionality: 20% of CBOT customer volume is for Giv